missing translation for 'onlineSavingsMsg'
Learn More

ML-18, MedChemExpress

Codice prodotto. 16499996
Encompass_Preferred
Cambia vista
Click to view available options
Quantità:
5 mg
10 mg
25 mg
50 mg
100 mg
Dimensione della confezione:
100mg
10mg
25mg
5 product options available for selection
Product selection table with 5 available options. Use arrow keys to navigate and Enter or Space to select.
Codice prodotto. Quantità Dimensione della confezione
16499996 50 mg -
16474696 100 mg 100mg
16453608 10 mg 10mg
16452786 25 mg 25mg
16426337 5 mg -
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 5 options available.
5 options
Les retours ne sont pas autorisés pour ce produit. Consulta la politica di reso
Codice prodotto. 16499996 Fornitore Medchem Express N. del fornitore HY101844
 Articolo soggetto a restrizioni
Spedizione stimata: 05-10-2026
Aggiungi al carrello
Aggiungi al carrello

missing translation for 'validMainframeMsg'

Les retours ne sont pas autorisés pour ce produit. Consulta la politica di reso

MedChemExpress ML-18 is a non-peptide bombesin receptor subtype-3 (BRS-3) antagonist with an IC50 of 4.8 μM.

ML-18 is a non-peptide bombesin receptor subtype-3 (BRS-3) antagonist with an IC50 of 4.8 μM.

Specifica

Materiale o nome chimico ML-18
CAS 1422269-30-4
Colore Light Yellow
Note sul grado di purezza Research
Formula molecolare C32H35N5O5
Quantità 50 mg
Informazioni di solubilità DMSO : ≥ 100 mg/mL (175.55 mM)
SMILES O=C([C@@H](NC(NC1=CC=C([N+]([O-])=O)C=C1)=O)CC2=CNC3=CC=CC=C23)NCC4(C5=CC=C(OC)C=C5)CCCCC4
Molecular Weight (g/mol) 569.65
Peso formulazione 569.65
Percent Purity 98.44%
Grado Research
Forma fisica Solid
Da utilizzare con (applicazione) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.